No approval for Covaxin, expert panel seeks more data from Bharat Biotech

NEW DELHI: The Subject Expert Committee of the Central Drug Standard Control Organization on Friday has held that the data provided by Bharat Biotech for its coronavirus vaccine 'Covaxin' is not sufficient for grant of emergency use approval and has asked for more information, top sources said. (IANS)

Also Watch: Promod Boro: Education, Agriculture Priority Areas of BTC

Also Read: COVID-19 challenge has given scope to innovate: PM Narendra Modi